Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 1, 2014, Pages

  Kwan, Sharon W ^a   Mortell, Kelly E ^b   Talenfeld, Adam D ^c   Brunner, Michael C ^d  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; AGED; ARTICLE; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; DEMOGRAPHY; EARLY CANCER; FEMALE; HUMAN; LUNG CANCER SPECIFIC SURVIVAL; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT HISTORY OF RADIOTHERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENESCENCE; SUBLOBAR RESECTION; SURVIVAL RATE; THERMAL ABLATION; TREATMENT OUTCOME; TUMOR ABLATION; VERY ELDERLY; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEAT; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LUNG RESECTION; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; UNITED STATES;

ABLATION TECHNIQUES; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HOT TEMPERATURE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; PNEUMONECTOMY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84896289598     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.10.018     Document Type: Article

References (26)

1. American Cancer Society Cancer Facts and Figures, 2012 2012 American Cancer Society Atlanta, GA
2. K.R. Yabroff, E.B. Lamont, and A. Mariotto et al. Cost of care for elderly cancer patients in the United States JNCI J Natl Cancer Inst 100 2008 630 641
3. P.B. Bach, J.N. Mirkin, and T.K. Oliver et al. Benefits and harms of CT screening for lung cancer: a systematic review JAMA 307 2012 2418 2429
4. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 discussion 622-623
5. J.A. Howington, M.G. Blum, A.C. Chang, A.A. Balekian, and S.C. Murthy Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 2013 e278S e313S
6. P.B. Bach, L.D. Cramer, J.L. Warren, and C.B. Begg Racial differences in the treatment of early-stage lung cancer N Engl J Med 341 1999 1198 1205
7. C.J. Simon, D.E. Dupuy, and T.A. DiPetrillo et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients Radiology 243 2007 268 275
8. M. Lanuti, A. Sharma, and S.R. Digumarthy et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 160 166
9. T. Hiraki, H. Gobara, H. Mimura, Y. Matsui, S. Toyooka, and S. Kanazawa Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer J Thorac Cardiovasc Surg 142 2011 24 30
10. L. Huang, Y. Han, and J. Zhao et al. Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg 39 2011 348 351
11. R. Lencioni, L. Crocetti, and R. Cioni et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol 9 2008 621 628
12. A. Zemlyak, W.H. Moore, and T.V. Bilfinger Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer J Am Coll Surg 211 2010 68 72
13. E.S. Alexander, J.T. Machan, T. Ng, L.D. Breen, T.A. DiPetrillo, and D.E. Dupuy Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? J Vasc Interv Radiol 24 2013 476 482
14. H.S. Park, S. Lloyd, R.H. Decker, L.D. Wilson, and J.B. Yu Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance Curr Probl Cancer 36 2012 183 190
15. L.A. Ries Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data Semin Surg Oncol 10 1994 21 30
16. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
17. L.S. Parson Using SAS software to perform a case-control match on propensity score in an observational study. Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference 2000 SAS Institute Inc Cary, NC
18. M. Okada, T. Koike, M. Higashiyama, Y. Yamato, K. Kodama, and N. Tsubota Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study J Thorac Cardiovasc Surg 132 2006 769 775
19. T. Koike, Y. Yamato, K. Yoshiya, T. Shimoyama, and R. Suzuki Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer J Thorac Cardiovasc Surg 125 2003 924 928
20. C.A. Grieco, C.J. Simon, W.W. Mayo-Smith, T.A. DiPetrillo, N.E. Ready, and D.E. Dupuy Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer J Vasc Interv Radiol 17 2006 1117 1124
21. S.K. Vinod, M.A. Sidhom, and G.P. Delaney Do multidisciplinary meetings follow guideline-based care? J Oncol Pract 6 2010 276 281
22. D.E. Dupuy, T. DiPetrillo, and S. Gandhi et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer Chest 129 2006 738 745
23. S.-H.I. Ou, J.A. Zell, A. Ziogas, and H. Anton-Culver Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003 Cancer 110 2007 1532 1541
24. G. Selvaggi, and G.V. Scagliotti Histologic subtype in NSCLC: does it matter? Oncology (Williston Park) 23 2009 1133 1140
25. M. Skrzypski, R. Dziadziuszko, and E. Jassem et al. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes Clin Lung Cancer 2013 S1525 S7304
26. M.S. Cepeda, R. Boston, J.T. Farrar, and B.L. Strom Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders Am J Epidemiol 158 2003 280 287